Detalles de la búsqueda
1.
Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
N Engl J Med
; 385(26): 2441-2450, 2021 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936740
2.
Spatial distribution and temporal trends of tuberculosis case notifications, Uganda: a ten-year retrospective analysis (2013-2022).
BMC Infect Dis
; 24(1): 46, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177991
3.
Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda.
BMC Infect Dis
; 24(1): 190, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350885
4.
Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022.
Emerg Infect Dis
; 29(3): 609-613, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823496
5.
Early culture conversion is a poor marker of treatment outcome among people with HIV and drug-resistant TB.
HIV Med
; 24(3): 335-343, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054688
6.
A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial.
BMC Public Health
; 23(1): 1568, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592314
7.
Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda.
BMC Health Serv Res
; 23(1): 1248, 2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957610
8.
Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
J Med Internet Res
; 25: e38828, 2023 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37252774
9.
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda.
Value Health
; 25(6): 924-930, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35667781
10.
Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment.
BMC Health Serv Res
; 22(1): 154, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123467
11.
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
PLoS Med
; 18(5): e1003628, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956802
12.
Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study.
BMC Infect Dis
; 21(1): 1093, 2021 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689736
13.
Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study.
BMC Public Health
; 21(1): 2167, 2021 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34836521
14.
Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers.
BMC Public Health
; 20(1): 1409, 2020 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32938411
15.
Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
BMC Infect Dis
; 19(1): 387, 2019 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064332
16.
Correction: Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study.
BMC Infect Dis
; 23(1): 44, 2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690968
17.
Strategies to resolve the gap in adolescent tuberculosis care at four health facilities in Uganda: The teenager's TB pilot project.
PLoS One
; 19(4): e0286894, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603636
18.
Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda.
J Acquir Immune Defic Syndr
; 95(5): 431-438, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489492
19.
Evaluation of Xpert ® MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
medRxiv
; 2023 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066316
20.
Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach.
Lancet Infect Dis
; 23(2): e59-e66, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963272